Primary Rituximab and Maintenance

NCT00140582 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1217
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Lymphoma Study Association

Collaborators